ArticleRadiation oncology (London, England)2026
Segment-specific PTV margins for rectal cancer radiotherapy on the MR-Linac: characterization of rectal motion and dosimetric validation.
Article in Radiation oncology (London, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundDose escalation in rectal radiotherapy shows promise for improving complete response rates and organ preservation, yet optimal expansion margins for rectal lesions remain unclear. This study aims to utilize high-resolution real-time imaging from MR-guided radiotherapy to characterize rectal motion uncertainties, optimize planning target volume (PTV) margins, and validate dosimetric outcomes, thereby enhancing the precision in rectal cancer dose escalation.
methodsA cohort of 22 advanced rectal cancer patients undergoing neoadjuvant radiotherapy on a 1.5T MR-Linac. Pre-treatment, intra-fraction, and post-treatment MR images were acquired for each fraction, with the rectum delineated according to the distance from the anus (upper, middle, lower). Inter- and intrafractional margins were determined by isotropic expansion of the segmented clinical target volume (CTV), with adequacy defined as covering 95% of the CTV volume in 90% of all fractions. Dosimetric validation was performed on 15 patients (10 internal, 5 external), comparing the segmental margins with literature-based uniform margins to assess target coverage and organs at risk (OARs) sparing.
resultsRectal motion variability was segment-dependent, with the upper rectum requiring the largest margins and the lower rectum the smallest. Interfractional margins for the upper, middle, and lower rectum were 13 mm, 7 mm, and 6.5 mm, respectively. Intrafractional analysis revealed that treatment duration also influenced margin requirements, with 7 mm for the upper rectum and 3 mm for the middle and lower rectum sufficient for durations under 30 min; longer durations necessitated slightly larger margins. Dosimetric analysis confirmed that the segmented margin expansion strategy achieves adequate target coverage while substantially sparing OARs with dose reductions ranging from 7.4% to 44.5%.
conclusionsSegment-specific margin expansion suggest a potential improvement for rectal radiotherapy, ensuring target coverage while reducing OAR dose, thereby facilitating organ and function preservation. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.